Prudential Financial
IRD

Prudential Financial’s Opus Genetics IRD Stock Holding History

Prudential Financial’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-13,100
Closed -$21.6K – 2480
2025
Q3 		$21.6K Buy
+13,100
New +$16.3K ﹤0.01% 2396
2024
Q2 		– Sell
-17,400
Closed -$35K – 2807
2024
Q1 		$35K Buy
17,400
+4,000
+30% +$10.1K ﹤0.01% 2621
2023
Q4 		$40.3K Buy
+13,400
New +$39.6K ﹤0.01% 2571

Other funds holding IRD

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

Prudential Financial's IRD Position: Q4 2025 in Review

Prudential Financial sold out of Opus Genetics (IRD) in Q4 2025, closing a stake of 13,100 shares — an estimated $21.6K sold.

Prudential Financial first reported a position in IRD in Q4 2023 and held it in 3 quarters. The position peaked at $40.3K in Q4 2023. 59 funds tracked by Wall St. Rank hold IRD as of Q4 2025.

  • Prudential Financial reported no remaining Opus Genetics position as of Q4 2025 after selling out during the quarter.
  • Prudential Financial sold 13,100 Opus Genetics shares in Q4 2025, an estimated $21.6K.
  • Prudential Financial first reported a position in Opus Genetics in Q4 2023 and held it in 3 quarters.
  • Prudential Financial's Opus Genetics position peaked at $40.3K in Q4 2023.
  • 59 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2025.

Based on Prudential Financial's 13F filing for Q4 2025, filed 13 Feb 2026.